T he field of cell and gene therapy is now starting to mature, as the number of reports of clinical safety and efficacy in patients has begun to increase 1 . Although the number of patients treated is small, the use of autologous human induced pluripotent stem cells as a treatment for macular degeneration appears to be safe 2 , and the ability of gene-corrected autologous epidermal cells to provide a long-lasting cure for a skin-blistering disease has been established 3 . The commercial and academic sectors have also been buoyed by the successes of cancer immunotherapies such as CAR T cell treatments 4 . Cell, tissue and organ replacement is needed to treat irreversible organ failure. However, in many cases of damage or disease, a better strategy might be to maintain and reinvigorate organ function in situ. This is an attractive option because it is likely to be less invasive and more costeffective than transplantation. Stimulating endogenous repair by manipulating stem cells and/or their niche is of growing interest, particularly as we come to understand more about the components of the cellular microenvironment 5 and start to exploit the recently revealed plasticity of differentiated cells in adult tissues 6 . Here we discuss different strategies for tissue repair and regeneration and consider the mechanisms by which cell plasticity is induced in adult tissues. Next, we consider the extent to which induced plasticity might be beneficial in reversing tissue ageing and the potential risk of plasticityassociated cancer. Finally, we remark on the feasibility of stimulating endogenous repair and regeneration to treat disease.
Some definitions
The stem cell field has evolved to the point at which past terminology and dogma are outdated in the context of the adult mammal and so it is worth revisiting some of the terminology. 'Repair' is probably the most straightforward term because it can be defined as restoring damaged tissue to good condition following insults such as ageing, disease and injury. Tissues differ widely in their ability to repair; the skin and gastrointestinal tract, for example, repair very effectively, whereas the brain is a tissue in which repair is highly inefficient. In the case of skin (Fig. 1) , although repair efficiently restores the barrier properties of the tissue, the repaired tissue may not be entirely normal; there may, for example, be scar formation and the repaired skin may be devoid of hair follicles. In situations in which new hair follicles form following wounding 7, 8 , we consider them to have regenerated (Fig. 1) . We consider the continuous replacement of epithelial cells that are shed from the surface of the skin or the lumen of the gut to constitute 'regeneration' , essentially a high rate of cell turnover under steady-state conditions. Therefore, regeneration is not obligatorily linked to tissue repair.
We now appreciate that daughter cells in several organs can exit the stem cell compartment and become increasingly lineage-restricted yet still retain the potential to revert to a stem cell state. This ability of a more differentiated cell to give rise to a stem cell, or the interconversion of distinct stem cell populations, constitutes 'plasticity' and has strong parallels with the terms 'dedifferentiation' and 'transdifferentiation' that are well known from classical embryology 9 ( Fig. 2) . Furthermore, the phenomenon of plasticity suggests that the historical concepts of cell fate specification and determination are not, as previously thought, irreversible. Plasticity also calls into question the meaning of 'terminal differentiation' , which is classically used to describe a unidirectional process by which post-mitotic differentiated cells are formed from a stem cell population. When such a cell lacks a nucleus, as is the case for human red blood cells or cells in the outer layers of human epidermis, there is no doubt that the state of differentiation is 'terminal' , meaning 'irreversible' . However, there are now many examples across organ systems in which cells that are committed to a specific lineage can re-enter the stem cell compartment after injury 6, 10 . Therefore, it would appear that even if the trajectory of a cell is towards a terminal state, different steps along the route may be reversible.
Finally, what is meant by 'quiescence'? Historically, this refers to cells that are not actively dividing and may have arrested in the G0 phase of the cell cycle. If such cells incorporate a DNA label in S phase, they may retain the label over many months or even years; however, these DNA label-retaining cells are not obligatorily arrested in G0 11 . In stem cell biology, quiescence is now generally taken to mean a dormant genome (heterochromatinization and low levels of global transcription) and metabolic dormancy (low protein translation and lack of oxidative phosphorylation) 12, 13 .
The caveats of cell lineage tracing
Inevitably, much of our understanding of the nature and properties of stem cells in adult tissues comes from lineage-tracing studies in mice. 
Review insight
This is a powerful technology, which enables us not only to trace the progeny of individual cells over many generations, but also to selectively ablate or expand specific populations. However, there are some technical constraints that must not be ignored. One is so elementary that it should not need to be discussed: it is unwise to assume that a marker that is expressed in a particular stem cell population is not also expressed in other cells elsewhere within the tissue. A good example of this is Lrig1, which is an excellent epithelial stem cell marker in a range of tissues, including the epidermis; however, it is also expressed in a highly dynamic manner in a subset of skin fibroblasts 14 . Except in pathological situations, in which epithelial cells can potentially invade the underlying connective tissue or undergo epithelial-mesenchymal transition, the gene of interest can still provide a highly useful reporter. Indeed, Lgr5 and Lgr6, which are often used as stem cell markers in a range of epithelia, are also expressed by mesenchymal populations in the lung 15 . Co-expression of the stem cell marker Lgr5 in differentiated cells or de novo expression following injury may have led to some confusion as to the source of regenerating cells. Following injury, increased numbers of Lgr5-lineage-traced cells have been seen in proliferative organs, such as the stomach 16 and skin, as well as relatively slow cycling organs, such as the liver 17 and pancreas 18 . In the stomach, Lgr5 is expressed in stem cells as well as chief cells following injury, and this highlights an ongoing debate on whether chief cells contribute to the regenerating gastric epithelium (Box 1).
The use of dual recombinase systems can overcome this weakness since lineage tracing relies on co-expression of two factors in the same cell 19 . This approach was used to revisit the concept that biliary epithelial cells can transdifferentiate into hepatocytes following injury, a concept for which there are contradictory results (Box 1). By using two separately encoded recombinase proteins (Sox9-CreER and AlbDreER), researchers have demonstrated that Sox9-expressing biliary epithelial cells did not form hepatocytes after injury. This is consistent with the emerging concept that biliary epithelial cells give rise to hepatocytes only under conditions in which hepatocytes are unable to divide 20, 21 . Other approaches for lineage tracing include barcoding and exploitation of naturally occurring DNA mutations. For example, an artificial DNA recombination locus (called Polylox) was recently developed for barcoding based on Cre-loxP recombination 22 . Polylox recombination in situ generates several hundred thousand barcodes, enabling the tagging of single cells in mice. These barcodes were then used for fate mapping of haematopoietic stem cells, which demonstrated that the adult haematopoietic stem cell compartment is a mosaic of clones that were present in the embryo and that most clones in the adult have multilineage differentiation potential. Newly developed CRISPR-Cas-based systems can be used to generate large-scale maps of cell lineages in multicellular systems for analyses of normal development and disease 23 . In terms of human lineage tracing, sun-exposed human skin has been a tractable system for many years and recent studies have inferred the clonal architecture of the epidermis based on DNA sequencing 24, 25 . In this case, a caveat that has emerged is that the interpretation of the data depends on how much skin is sequenced to capture the largest mutant clones. When sufficiently large areas of skin are sequenced, it is possible to infer the effects of primary and secondary mutations, leading to the conclusion that secondary mutations arising at the edge of a mutant clone have a selective growth advantage 26 . Largescale single-cell gene expression profiling of adult human tissues will Review insight undoubtedly improve our understanding of the inter-relationships between cell states, cell types and lineages 27 .
Cell-intrinsic mechanisms of plasticity
Plasticity of adult tissues can be apparent as dedifferentiation or transdifferentiation from one cell type into another 28 ( Fig. 2) . Although in most cases plasticity is linked to injury, this is not an obligatory association. In the epidermis, for example, switching between stem cell populations and fate switching between differentiated lineages can be induced by β-catenin activation in the undamaged epidermis 29 . It is possible that this occurs because the epidermis in which β-catenin is activated can reprogram the underlying connective tissue, the dermis, to a neonatal state by secretion of signalling molecules such as sonic hedgehog 8, 30 . In support of this, the hair follicle defects that result from deleting the transcriptional co-activator Blimp1 in the dermis are rescued by epidermal β-catenin activation 31 . There are also numerous examples of the use of transcription factors to induce plasticity by cell-autonomously modulating gene expression. This is evident in the pancreas, which exhibits very limited regenerative potential under homeostatic conditions, yet harbours a latent multipotent cell type that can be activated 32 . Expression of endocrine-promoting transcription factors in the exocrine cells of the pancreas triggers their conversion to insulin-expressing cells capable of reversing diabetes 33 . Inactivation of the SCF-type E3 ubiquitin ligase substrate recognition component Fbw7 induces pancreatic ductal cells to reprogram into α, δ and β cells and acts by stabilizing the transcription factor Neurog3, a known regulator of endocrine cell differentiation 34 .
Injury-induced plasticity
The induction of pluripotency by the expression of transcription factors demonstrates that plasticity can be experimentally induced in almost all somatic cells 98 . However, in nature, plasticity is most commonly associated with tissue injury and damage (Box 1). Injuries can occur in a number of ways, such as by targeted laser ablation 35 , tissue disaggregation 10 or full-thickness wounds 7, 36 in the skin. In the intestine, diphtheria toxin receptor (DTR)-mediated stem cell ablation 37 or 5-fluoro-uracilmediated killing of proliferative cells 38 causes secretory and absorptive progenitors to acquire intestinal stem cell-like properties and contribute to regeneration. A rare population of cells in the crypt that appears to consist of enteroendocrine cells also expresses stem cell markers and can broadly contribute to epithelial regeneration following irradiation 39 . Although some experimental forms of injury such as DTR-mediated killing of genetically marked cells are not normal physiological conditions, the effects of Helicobacter pylori in the stomach are. Chronic injury caused by H. pylori infection can directly amplify the regenerative response and cause a number of epithelial changes, including loss of parietal cells and confusion of cellular identity of chief cells 40 .
Plasticity is not limited to the epithelial compartment of tissues. For example, regeneration of adipocytes from dermal myofibroblasts during wound healing in the skin has recently been demonstrated 41 . This occurs through the interaction with hair follicles that are forming in the wound. The hair follicles trigger bone morphogenetic protein (BMP) signalling and activation of adipocyte transcription factors. Indeed, it has been suggested that fibrosis occurs not only as a consequence of aberrant signalling but also because of aberrant differentiation of a particular subpopulation of fibroblasts 42 .
Inflammation and infection-induced plasticity
Microbe-and injury-induced inflammatory responses are mediated by cells of the innate immune system, which produce and respond to cytokine mediators and other inflammatory signals. Tissue-resident cells sense these signals and respond by migrating, proliferating and regenerating the tissue 43 . Mechanisms linking inflammation to damage repair and regeneration in mammals are conserved in lower organisms 44 . In terms of immune modulation of stem cells and regeneration, evolutionary advances in the immune system appear to be inversely correlated with the ability to fully regenerate injured tissues 45 . There are a number of ways in which the immune system can facilitate endogenous repair. For example, there is a strong link between macrophage-mediated debris clearance and regeneration in the central nervous system 45 and macrophages are essential for effective wound healing in the skin 46 . In addition, immune cells can activate proliferation: in undamaged skin, Notch-mediated communication between regulatory T cells and hair follicle stem cells is required for hair follicle growth 47 . Regulatory T cells can also activate muscle satellite cells following injury 45 . In addition, TIE2-expressing monocytes/macrophages promote revascularization of ischaemic limbs 48 . Inflammation also facilitates repair through the modulation of stem cell regulatory proteins such as Lgr5. Lgr5 is a Wnt target gene and macrophages are a known source of Wnt ligands in a variety of contexts including ulcerative colitis 49 . Lgr5 is also directly regulated by inflammatory mediators. In basal cell carcinoma, IKKα directly binds to the Lgr5 promoter and regulates transcription of Lgr5 50 . In the intestine, interleukin-22 acts via Stat3 to promote epithelial regeneration 51 . Therefore, immune cells could mediate an increase in plasticity through direct regulation of stem cell pathways.
In addition to these roles for inflammation in tissue repair, recent data suggest that inflammation can trigger epigenetic memory of injury 52 and that innate immune signalling pathways can have a role in nuclear reprogramming (transflammation 53 ), for example via reactive oxygen species. If inflamed skin is wounded, heals and is then re-wounded, the second wound heals more rapidly 52 . This is because epidermal stem cells maintain chromosomal accessibility to key Review insight stress response genes that are activated by the original inflammatory stimulus. This memory depends on the intracellular DNA sensor absent in melanoma 2 (Aim2), which encodes an activator of the inflammasome. In the absence of Aim2 or its downstream effectors the epidermal memory is erased. More broadly, intracellular nucleic acid sensors can discriminate between self and non-self nucleic acids 54 , opening up the possibility that pathogens can induce plasticity in adult tissues by a similar mechanism.
Cell-extracellular matrix and cell-cell adhesion
In addition to inducing inflammation, injury induces changes in the adhesive interactions between cells and their environment. Epithelial damage can lead to loss of basement membrane proteins and deposition of new extracellular matrix (ECM) with a different protein composition. It can also lead to loss of neighbouring cells and interactions with new neighbours, linked, for example, to cell migration 10 . Inevitably, the fine patterning of niches, leading to local and spatially distinct signals in undamaged tissue 55 , is destroyed after tissue damage. Recent studies have demonstrated that physical factors play a key part in determining tissue architecture under steady-state conditions. For example, the undulations of the human epidermal-dermal junction are instructive in epidermal stem cell clustering 56 . Crowding in the epidermal basal layer affects cell shape; a decrease in cortical tension, and increased cell-cell adhesion trigger differentiation and movement of cells into the suprabasal layers 57 . Piezo1 has a role in linking mechanical stretch to division of epithelial cells 58 . One of the key integrators of cell position and cell fate in the epidermis and other tissues is YAP activity [59] [60] [61] . YAP integrates diverse signals, including Notch, Wnt and ECM signals 61, 62 , and intercellular adhesion 60 . In mice, YAP has a key role in cell fate transitions during colonic regeneration following injury 62 . The colonic epithelium is transiently reprogrammed into a primitive, fetal-like state via ECM remodelling, FAK-Src signalling and YAP activation.
One general mechanism by which injury can induce plasticity is by modulation of the actin cytoskeleton. For example, Rho-kinase inhibition expands epithelial stem cells in culture, including cells from the mammary gland, prostate, intestine and colon 63, 64 . Similarly, inhibition of dual SMAD signalling enables long-term expansion of basal cells in a variety of epithelia, both in vivo and in vitro 65 . TGFβ-BMP-SMAD signalling is activated in differentiated cells of multiple epithelia, including lung, mammary gland, stomach and epidermis, and is suppressed in basal cells that express the transcription factor p63. In lung airway epithelium, SMAD signalling promotes differentiation, whereas SMAD inhibition leads to stem cell hyperplasia. These findings are likely to be relevant in epithelial cancers. For example, suprabasal expression of the α6β4 integrin in mouse epidermis increases tumour formation in part by relieving TGFβ-mediated growth inhibition 66 .
Ageing and regeneration
Tissue integrity, organ function and regenerative capacity all decline with age 67 . Despite an obvious relevance to human health, there are relatively few studies about changes in regeneration/homeostasis with age, possibly due to the technical and financial burdens of studying 'old' animals. Factors that are likely to be involved include loss of stem cell number and proliferative capacity, ECM remodelling towards a more fibrotic phenotype, and cumulative DNA damage causing cellular senescence (Fig. 3) . It is clear that stem cell extrinsic factors, such as fibrosis caused by chronic inflammation, accelerate these processes. However there are also age-linked cell-intrinsic changes in stem and progenitor cells. Age-related changes in tissue-resident stem cells have been observed in a range of tissues, including blood, skin and intestine 67 . Some age-related changes are cell-intrinsic, since stem cells isolated from aged patients grow poorly in culture relative to their young counterparts. The cell-intrinsic mechanisms that drive stem cell ageing include loss of telomeres, epigenetic changes 68 , decline in mitochondrial function 69 and accumulation of DNA mutations 70 . In the intestine, telomere shortening is linked to Wnt inactivity and stem cell failure 71 . The cellular safeguards to cancer, including programmed cell death, senescence and differentiation, might be responsible for reduced stem cell number and activity as we age. How mutations are coupled to the number of stem cell replications has been discussed previously 70 as well as how this might cause the well-known increase in cancer risk with age. An increase in mutation load in stem cells would be expected to correlate with increased cell death and senescence, resulting in the loss of stem cell number or proliferative capacity.
The therapeutic possibility of rejuvenating aged organs is best exemplified by parabiosis experiments. Parabiosis, the surgical linking of the circulatory systems between old and young animals, results in the restoration of stem cell activity in the organs of old mice. Moreover, a single transfusion of old blood causes a rapid loss of stem cell activity in young mice, demonstrating the negative effects of circulating factors in old animals 72, 73 . 88, 89 , whereas corpus stem cells express Sox2, Lrig1 and Mist1 [90] [91] [92] . Chief cells are long-lived, highly specialized, pepsinogen-producing cells and become recruited to contribute to epithelial repair following injury 16, 38 . Liver. The liver largely consists of two cell types, hepatocytes and cholangiocytes. A subpopulation of Wnt-responsive hepatocytes maintains the liver under steady-state conditions 93 . After a partial hepatectomy, the remaining hepatocytes divide until the original liver mass is restored and then return to a non-proliferative state 94 . By contrast, when there is acute or chronic damage to hepatocytes such that they are unable to proliferate, cholangiocyte-like cells near the bile duct tree regenerate hepatocytes and cholangiocytes 20, 21 . Similarities in regeneration and plasticity across gastrointestinal organs. There are vast structural and functional differences in the epithelium of gastrointestinal organs. The stratified squamous epithelium of the oesophagus has little cellular diversity, whereas the stomach is a complex glandular mucosa, and the intestine consists of a diverse mix of absorptive and secretory cell types. Nevertheless, these organs share many features. The entire epithelium of the gastrointestinal tract derives from a single layer of embryonic endoderm 95 and similar signalling pathways control epithelial homeostasis in the different organs. Canonical Wnt signalling is involved in maintaining and expanding stem and progenitor cells, whereas BMP and Notch signalling promote differentiation of the various epithelial lineages. Indeed, there is evidence that the caudal homeobox transcription factor Cdx2 is the single factor that functionally distinguishes an intestinal from a gastric stem cell 96, 97 . It is not clear why gastrointestinal stem cells have so many similarities, but it could be a primitive epigenetic memory owing to their shared cellular origin during embryonic development.
Review insight cells 74 or might act to remodel and rejuvenate the niche 75 . Circulating factors that might modulate the niche include ECM proteins, growth factors and immune cells. In the skin, age-associated proteolysis of type-XVII collagen results in hair follicle miniturization and epidermal hypertrophy, which can be reversed by re-expressing that collagen subtype 76, 77 . Soluble growth factors and cytokines, such as Wnt and interleukin-22, can reverse age-related declines in intestinal stem cells 51, 78 . One of the most recent approaches to rejuvenate organs is through the targeted removal of senescent cells in the niche 79 .
Plasticity and cancer
The obvious downside of inducing plasticity for tissue rejuvenation is the risk of cancer. Inflammation-induced lineage infidelity in the epidermis is transient in wounds but persists in cancer 36 . Specific chromatin states prime cells in squamous cell carcinoma to undergo epithelialmesenchymal transition 80 . A further finding is that neighbouring wild-type cells have the ability to correct aberrant epidermal behaviour of cells that have β-catenin mutations 81 . There are multiple examples linking cellular plasticity and cancer in the gastrointestinal tract. In the stomach, induction of plasticity in differentiated cells occurs during chronic injury, in which chief cells co-express mucous neck cell markers (TTF2, which is also known as spasmolytic polypeptide) in a precancerous lesion termed SPEM (spasmolytic polypeptide expressing metaplasia) 82 . A further example of cancer-associated plasticity is intestinal metaplasia, in which the oesophagus or stomach epithelium converts to an intestinal epithelium. In the case of Barrett's oesophagus, an intestine-like metaplasia and precursor of oesophageal adenocarcinoma is triggered by gastrooesophageal reflux. Recently it has been suggested that transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus 83 .
Therapeutic prospects
Treatments that target the niche are already being evaluated to treat cancer 5, 84 and this Review has highlighted a number of strategies that could be exploited to promote tissue regeneration. Looking into the future, computational analysis of cell state transitions indicates that it may be possible to pharmacologically stabilize particular cell stateswhether stem cell, committed cell or differentiated cell-for therapeutic benefits 85 . In addition, mining large datasets of single-cell gene expression profiles 86 is likely to enhance our understanding of different cell types and states and the pathways by which they are specified.
One concern is whether the induction of plasticity will ever be therapeutically relevant, given that the proportion of cells in a tissue that exhibit plasticity is often exceptionally rare 37, 38 . Time will tell, but it is worth concluding with the observation that gastric bypass surgery in humans enhances pancreatic β-cell function and may also increase β-cell mass 87 . While it is not clear whether this involves injury-induced plasticity, it is proof that a surgical intervention can have unanticipated therapeutic benefits. 
